pc ¹öÀüÀ¸·Î À̵¿ Áß [½ÃÀ庸°í¼­]¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¹ÙÀÌ¿À¸®¾×Åͺ°, ¿ëµµº°, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºº°, Á¦Ç°º°(»ùÇøµ ½Ã½ºÅÛ, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×À̳Ê, ¹ÙÀÌ¿À¸®¾×ÅÍ, ±âŸ), ¸ð´Þ¸®Æ¼º°, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2022-2028³â)
¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¹ÙÀÌ¿À¸®¾×Åͺ°, ¿ëµµº°, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºº°, Á¦Ç°º°(»ùÇøµ ½Ã½ºÅÛ, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÄÁÅ×À̳Ê, ¹ÙÀÌ¿À¸®¾×ÅÍ, ±âŸ), ¸ð´Þ¸®Æ¼º°, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2022-2028³â)
Single Use System in Biopharma Manufacturing Market, By Bioreactors, Application, Bioprocessing, Product (Sampling Systems, Bioprocess Containers, Bioreactors, & Others ), Modality & Geography-Size, Share, Outlook, & Opportunity Analysis, 2022-2028
»óǰÄÚµå : 1136985
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2022³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
US $ 4,500 £Ü 5,599,000
PDF (Single User License)
US $ 7,000 £Ü 8,710,000
PDF (Multi User License)
US $ 10,000 £Ü 12,444,000
PDF (Enterprise User License)


Çѱ۸ñÂ÷

½ÃÀå ¿ªÇÐ

¹ÙÀÌ¿À½Ã¹Ð·¯ ÀǾàǰÀ̳ª »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø Áõ°¡, ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ë°ú ¼ö¿ä Áõ°¡, Ä¡·á ºÒ°¡´ÉÇÑ ÁúȯÀ» Ä¡·áÇÏ´Â ¹ÙÀÌ¿ÀÀǾàǰÀÇ ´É·Â, ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ »ê¾÷ÀÇ ¼ºÀåÀº ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¹ÙÀÌ¿À¸®¾×Åͺ°, 2017-2028³â

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°, 2017-2028³â

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºº°, 2017-2028³â

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°, 2017-2028³â

Á¦9Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ¸ð´Þ¸®Æ¼º°, 2017-2028³â

Á¦10Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, 2017-2028³â

Á¦11Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿ë ÀÏȸ¿ë ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°, 2017-2028³â

Á¦12Àå °æÀï »óȲ

Á¦13Àå ¼½¼Ç

KSM 22.10.27
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Single use systems (SUS) refers to biopharmaceutical manufacturing equipment designed to be used once and then discarded. These systems are being increasingly used as an alternative to stainless-steel equipment for biopharma manufacturing. Single-use technologies offer both efficient & cost-effective way to manufacture biopharmaceuticals. In short, single use systems or technologies provide solutions that address the bioprocessing needs in the development and manufacturing of biopharmaceuticals. For instance, biopharmaceutical companies worldwide use single-use system to manufacture drugs and vaccines.

Market Dynamics:

Rising government support towards biosimilar & biological drugs, increasing acceptance and demand for biopharmaceuticals, ability of biopharmaceuticals to treat untreatable diseases, and growing biopharmaceutical manufacturing industry are some major factors expected to aid in the growth of the global single use system in biopharma manufacturing market.

In February 2021, Bristol Myers Squibb granted an exclusive license to develop, manufacture, and commercialize Rockefeller's novel monoclonal antibody duo treatment that neutralizes the SARS-CoV-2 virus for therapy or prevention of COVID-19.

Moreover, in March 2020, Thermo Fisher Scientific Inc. invested around US$ 475 million to expand its biologics, cell therapy and gene therapy, and drug product development facilities and increase its global commercial capabilities.

Key features of the study:

Detailed Segmentation:

Table of Contents:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Single Use System in Biopharma Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Single Use System in Biopharma Manufacturing Market, By Bioreactors, 2017-2028, (US$ Mn)

6. Global Single Use System in Biopharma Manufacturing Market, By Application, 2017-2028, (US$ Mn)

7. Global Single Use System in Biopharma Manufacturing Market, By Bioprocessing, 2017-2028, (US$ Mn)

8. Global Single Use System in Biopharma Manufacturing Market, By Product, 2017-2028, (US$ Mn)

9. Global Single Use System in Biopharma Manufacturing Market, By Modality, 2017-2028, (US$ Mn)

10. Global Single Use System in Biopharma Manufacturing Market, By Component, 2017-2028, (US$ Mn)

11. Global Single Use System in Biopharma Manufacturing Market, By Geography, 2017-2028, (US$ Mn)

12. Competitive Landscape

13. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â